Nutraceuticals: Reviewing their Role in Chronic Disease Prevention and Management [0.03%]
营养补充剂:评估其在慢性疾病预防和管理中的作用
Amanda Bergamin,Evangeline Mantzioris,Giordana Cross et al.
Amanda Bergamin et al.
Over half the adult population in many Western countries consume nutraceuticals because of their purported therapeutic benefits, accessibility and convenience. Several studies have demonstrated that they may also serve as a useful adjunct t...
Adverse Drug Reaction Risk Measures: A Comparison of Estimates from Drug Surveillance and Randomised Trials [0.03%]
药物不良反应风险测定:基于药物监测和随机临床试验估算结果的比较
Raphaelle Beau-Lejdstrom,Sarah Crook,Alessandra Spanu et al.
Raphaelle Beau-Lejdstrom et al.
Background: Most drug regulatory agencies and pharmaceutical companies hold databases of spontaneous reports of suspected adverse drug reactions (ADRs). Detection systems for ADR signals have been created by specialists t...
Amber Barnes,Susan Patrick
Amber Barnes
The European Union Clinical Trials Regulation (EU CTR) 536/2014 includes a requirement for the submission of lay summaries. Study participants, advocacy groups, and, to a lesser extent, the general public have called for greater transparenc...
Current Prospects of Molecular Therapeutics in Head and Neck Squamous Cell Carcinoma [0.03%]
头颈部鳞状细胞癌分子靶向治疗的现状与前景
K Devaraja
K Devaraja
Head and neck squamous cell carcinoma (HNSCC) has an estimated annual global death rate of approximately 300,000. Despite advances in surgical techniques, the advent of efficient radiation delivery methods, and the introduction of newer che...
Association of Adverse Drug Events with Hospitalization Outcomes and Costs in Older Adults in the USA using the Nationwide Readmissions Database [0.03%]
美国老年人大样本再入院数据库中不良药物事件与住院结果和费用之间的关联性分析
Munaza Riaz,Joshua D Brown
Munaza Riaz
Background: Adverse drug events (ADEs) are a primary cause of significant morbidity, mortality, and healthcare utilization in older adults. Objective: ...
Observational Study
Pharmaceutical medicine. 2019 Aug;33(4):321-329. DOI:10.1007/s40290-019-00286-z 2019
Association Between Health-Related Quality of Life Measures and Survival Endpoints in Oncology Clinical Trials and in Clinical Decision Making: A Narrative Review [0.03%]
基于肿瘤临床试验和临床决策中健康相关生活质量指标与生存终点之间关联性的叙述性文献回顾
For decades, oncology research has primarily relied on survival-based endpoints, such as progression-free survival and overall survival, to evaluate treatment efficacy. However, recent studies and international guidelines underscore the imp...